Barclays
NUVL

Barclays’s Nuvalent NUVL Stock Holding History

Barclays’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157M Buy
1,268,265
+1,237,421
+4,012% +$133M 0.03% 379
2026
Q1 		$3.16M Sell
30,844
-94,484
-75% -$9.63M ﹤0.01% 2094
2025
Q4 		$12.6M Sell
125,328
-1,552
-1% -$153K ﹤0.01% 1517
2025
Q3 		$11M Sell
126,880
-22,726
-15% -$1.8M ﹤0.01% 1599
2025
Q2 		$11.4M Buy
149,606
+53,569
+56% +$3.92M ﹤0.01% 1483
2025
Q1 		$6.81M Sell
96,037
-2,084
-2% -$163K ﹤0.01% 1680
2024
Q4 		$7.68M Buy
98,121
+30,014
+44% +$2.8M ﹤0.01% 1784
2024
Q3 		$6.97M Buy
68,107
+40,754
+149% +$3.38M ﹤0.01% 1768
2024
Q2 		$2.07M Sell
27,353
-4,097
-13% -$291K ﹤0.01% 2114
2024
Q1 		$2.36M Sell
31,450
-56,655
-64% -$4.51M ﹤0.01% 2433
2023
Q4 		$6.48M Buy
88,105
+36,862
+72% +$2.28M ﹤0.01% 1877
2023
Q3 		$2.36M Buy
51,243
+8,010
+19% +$356K ﹤0.01% 1787
2023
Q2 		$1.82M Buy
43,233
+11,710
+37% +$443K ﹤0.01% 1948
2023
Q1 		$822K Buy
31,523
+2,085
+7% +$61.7K ﹤0.01% 2884
2022
Q4 		$877K Buy
29,438
+28,721
+4,006% +$801K ﹤0.01% 2911
2022
Q3 		$14K Sell
717
-131
-15% -$2.19K ﹤0.01% 4185
2022
Q2 		$11K Sell
848
-2,128
-72% -$22.5K ﹤0.01% 4601
2022
Q1 		$41K Buy
+2,976
New +$43.2K ﹤0.01% 4194

Other funds holding NUVL

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Barclays's NUVL Position: Q2 2026 in Review

Barclays increased its Nuvalent (NUVL) stake by 4,012% in Q2 2026, buying an estimated $133M and bringing the position to 1,268,265 shares worth $157M. The position accounts for 0.03% of the portfolio, ranked #379.

Barclays first reported a position in NUVL in Q1 2022 and has held it in 18 quarters since. 292 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Barclays held 1,268,265 shares of Nuvalent worth $157M as of Q2 2026.
  • Barclays bought 1,237,421 Nuvalent shares in Q2 2026, an estimated $133M.
  • Nuvalent made up 0.03% of Barclays's portfolio in Q2 2026, its #379 holding.
  • Barclays first reported a position in Nuvalent in Q1 2022 and has held it in 18 quarters since.
  • 292 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.